Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.
about
Membrane TNF confers protection to acute mycobacterial infection.Granuloma formation in pulmonary sarcoidosisCreation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonistSoluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathologyDifferential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules.How tumour necrosis factor blockers interfere with tuberculosis immunity.Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infectionADAM17-mediated processing of TNF-α expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury.Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.Membrane tumor necrosis factor confers partial protection to Listeria infection.Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNFInhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonistsControl of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.Development of novel drug delivery systems using phage display technology for clinical application of protein drugsTransmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infectionLow Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability.The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infectionSoluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.Biologics in children's autoimmune disorders: efficacy and safety.Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences.A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infectionMultiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.In vitro inhibition of lipopolysaccharide and mycobacterium bovis bacillus Calmette Guérin-induced inflammatory cytokines and in vivo protection from D-galactosamine/LPS -mediated liver injury by the medicinal plant Sclerocarya birrea.T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection.Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.Lipoarabinomannan Decreases Galectin-9 Expression and Tumor Necrosis Factor Pathway in Macrophages Favoring Mycobacterium tuberculosis Intracellular Growth.Soluble TNF-alpha but not transmembrane TNF-alpha sensitizes T cells for enhanced activation-induced cell death.Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.
P2860
Q25257300-1561CB95-FA5A-4D61-A7DD-3F06CB50D473Q26863703-3D4FDB47-D0F3-4458-AECA-14B30274B190Q27649040-3D245CE5-3AFF-4328-81BE-C6C004AAA95CQ33723788-22A0A7F8-0E9B-40F3-BC10-FC6F2438269BQ33787988-A679C47F-1971-49AB-A372-0BBCA63770B1Q33915940-7912F20F-628A-44E6-9B3A-B4D9BBAEBA03Q34065405-33AAECFC-45B4-463B-AE88-4535E4A4489AQ34111943-6B775BB9-DDB3-4FE0-A633-4D56D44711B8Q34134720-00036E16-44C2-42CD-B87C-ABE1A732DEA8Q34292364-AD78BF1E-D328-4D78-A194-23571E933C94Q34660051-9BFC9716-04F7-47A9-A12F-AF36D2C83C2FQ34681089-825DB302-5D4E-4937-B884-0EA9787F69A6Q35040269-999B82BA-33E6-4966-BB08-1E6D5ACF9262Q35083799-E175E9C1-E575-455C-929D-5EDE09CAEE3CQ35094506-617D906A-D834-42AD-A30B-733704F4C22CQ35553478-CB0CC8CB-73C0-4EF2-843F-ABCAFE87AA97Q35605635-8EB3AC89-9664-4F39-B244-27028BA0FFBEQ35947483-22819737-CECF-4389-A69D-5F18A96E27F4Q37033735-CF6232F0-A40D-4C84-8841-8C6660C934CCQ37198453-2EEF24AD-E6C5-4695-8AE3-665F8E13E925Q37333359-DC22395F-7F75-40F4-A79F-6C50C8DF8DE8Q37385874-76E7881D-E85E-4157-86F2-ADCDE4CFEDDAQ37655910-7A34A546-83D0-4A81-A70D-B44C5C5D4964Q37679983-EC7EB508-0A83-4D56-9304-BAAECEE32053Q37765830-B339316E-79E1-4642-8920-9C754B4D4652Q38673326-BF9D782A-316E-4078-939B-0212726A75ADQ38714957-34BF02CE-DC63-4B61-9F54-7E88D88603D0Q38793309-AE9FEF0A-317B-4A5F-A9E8-A0D62D6537A7Q40054580-D12FCBF1-7EDA-4755-855A-C9CB4ED9F35BQ40483759-19CE72A7-8361-4533-8B94-190452F3EA4EQ42047613-5CA8EAB8-2241-49A6-A87C-B8912E2B17F8Q43105938-F3EFA4F8-A321-41E2-9C55-75E71BCBA23FQ43863784-99BC3073-7733-44EC-9E48-91DFB98CB315Q44422799-B7D4D428-06A2-46E1-92D3-C612F1C57BBAQ45929497-738184C2-D913-4A65-BB56-058F9046CA93Q46773827-62017AE1-7400-44F1-AEA2-35419B96AA8DQ47098248-EA5CBEA4-457E-4D8B-911A-B97D357C075EQ53377749-44B996ED-F164-4316-B4ED-8814AEE54D88Q53668818-17E24E12-44C1-4C68-B5D8-425BC37FDC7EQ55027807-557986FE-742D-49FB-B314-DEBCFF9E0E48
P2860
Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@en
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@nl
type
label
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@en
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@nl
prefLabel
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@en
Transmembrane TNF induces an e ...... ted TNF and lymphotoxin-alpha.
@nl
P2093
P1476
Transmembrane TNF induces an e ...... eted TNF and lymphotoxin-alpha
@en
P2093
Dominique Vesin
Gilles Marchal
Hans-Pietro Eugster
Irene Garcia
Maria L Olleros
Nadia Corazza
Pierre Chavarot
Reto Guler
P304
P356
10.4049/JIMMUNOL.168.7.3394
P407
P577
2002-04-01T00:00:00Z